Cell Reserves Inc. With a mission to develop novel therapeutics, they focus on the next generation of bio-pharmaceuticals using molecular shields. These shields enhance the persistence and bio-availability of therapeutics in the circulation, especially for autoimmune diseases.

By utilizing a simpler, modular, and practical platform technology, Cell Reserves Inc. They also explore nasal and oral delivery methods, allowing for faster penetration into hard-to-reach areas such as solid tumors and tissues. Their pipeline currently focuses on developing new treatments for autoimmune diseases, including myasthenia gravis, pemphigus, lupus, and arthritis.

Through proprietary ligands that inhibit important regulatory receptors, Cell Reserves Inc. Cell Reserves Inc. For further information or collaborations, please email sqs@cellreserves.

com